InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: None

Sunday, 08/23/2015 8:09:27 PM

Sunday, August 23, 2015 8:09:27 PM

Post# of 403159
Harry Potter and CTIX: I open at the close.(Read on)

So what is new re K? Before the recent attack, in April, CEO already said stuff NOT said at ASCO, that "some" tumors stabilized and that p21 increases were dose dependent. Truly new?

1- more specific info about stabilization on CT scans of ovarian CA pts at 3 and 6 months
2-one thymoma pt has been stable for 11 months
3-additional info about p21 and gyn malignancies
4-2/2 prostate ca pts increased p21

what we wanna know:

later cohort responses
new dosing regimens
publish the dose response data when you can

CEO says phase 1 near to a close.

For you Harry Potter fans who recall the phrase open at the close: I predict: as Phase 1 closes the very wide and spectacular possibilities of kevetrin will open:

K + cytarabine + sunitinb + cisplat + immunotherapy + radiation for all those cancers out there..
That is the future that I think we will see.

Will it come true? No one knows right now but all eyes are on the next bits of info. How much more will we know as phase 1 ends, vs next phases with more specific treatments and combo therapies?

I sense this is the real deal and have invested accordingly. K could also flop- that is still entirely possible. Leo cherrypicks early data that will tell a false tale in the end? Or, early data promising, the story unfolds?

That is the real drama here, as we all know, not the short term ups and downs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News